In the Boardroom
Refine Search
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Biosimilars
Biologics specialist Repligen has appointed Tony Hunt as the company’s next chief executive officer. 21 January 2015
Biotechnology
Drug delivery and dosage specialist EastGate Biotech Corp has appointed Rose Perri as president. 21 January 2015
Biotechnology
AiCuris, a company formed by experts from Bayer's virology and bacteriology research divisions, is to have a lineup change in its senior management. 21 January 2015
Pharmaceutical
US pharma major Bristol-Myers Squibb yesterday announced a number of leadership changes approved by its board of directors and effective at the close of the annual shareholders’ meeting on May 5. 21 January 2015
Pharmaceutical
The pharmaceutical industry faces a number of unique challenges when recruiting staff. Unlike in many other sectors, when things go wrong, there is not just a risk to a company’s finances and reputation but also to public health. It’s vital to get it right, writes Steve Girdler, managing director EMEA at HireRight, the candidate due diligence company. 15 January 2015
Pharmaceutical
Japanese drug major Astellas Pharma has appointed Eric Terhaerdt as senior vice president of global development operations. 15 January 2015
Biotechnology
Immunotherapy specialist Immune Therapeutics has appointed Seth Elliott as president and chief operating officer. 14 January 2015
Pharmaceutical
Belgian drugmaker UCB has replaced chief executive Roch Doliveux with Jean-Christophe Tellier. 13 January 2015
Pharmaceutical
Pharma company Hovione has appointed Filipe Gaspar as vice president of its research and development organization. 12 January 2015
Pharmaceutical
KaloBios Pharmaceuticals has announced its president and chief executive, David Pritchard, is to retire. 11 January 2015
Biotechnology
Dutch gene therapy specialist uniQure has appointed Matthew Kapusta as chief financial officer. 9 January 2015
Pharmaceutical
Aveo Oncology has appointed Michael Bailey as president, chief executive and director. 7 January 2015
Pharmaceutical
Ophthalmic specialist ThromboGenics NV has appointed Dominique Vanfleteren as chief financial officer. 7 January 2015
Biotechnology
Isis Pharma, the biopharma Crohn’s disease specialist, has appointed Sarah Boyce to the newly-created chief business officer position. 7 January 2015
Pharmaceutical
Women’s health specialist Columbia Laboratories has appointed Bridget Martell to the newly-created position of chief medical officer. 6 January 2015
Biotechnology
Oncology biotech company CytomX has appointed Michael Kavanaugh as chief scientific officer and head of research and early development. 5 January 2015
Pharmaceutical
Synthetic cannabinoid specialist Zynerba Pharmaceuticals has appointed Richard Baron as vice president and chief financial officer. 5 January 2015
Pharmaceutical
Medical device company Echo Therapeutics has appointed Alan Schoenbart as chief financial officer. 2 January 2015
Pharmaceutical
Japan’s largest drugmaker Takeda Pharmaceutical has appointed Andy Plump as corporate officer and chief medical and scientific officer designate. 19 December 2014
Biotechnology
Immunotherapeutic company PDS Biotechnology has made Richard Sykes executive chairman of its board of directors. 18 December 2014
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze